-
To determine practices regarding use of closed-system suctioning (CSS) and airway management of intubated patients, Sole and colleagues surveyed a national sample of 1665 registered nurses (RNs) and respiratory therapists (RTs) in 27 institutions.
-
Warren and colleagues performed a nonrandomized pre- and postobservational trial of an educational intervention to prevent catheter-associated bloodstream infections (CABSIs) in a 500-bed private community hospital in Missouri.
-
Azithromycin is an effective, single-drug therapy for mild-to-moderate community-acquired pneumonia.
-
Eighty-seven percent or more of patients with fatal or nonfatal myocardial infarction have major risk factors prior to the event.
-
Patients with unexplained chronic fatigue and bodily pain are more likely to have rhinosinusitis symptoms than are people in the general population.
-
-
Insulin 70/30 Mix Plus Metformin vs Triple Oral Therapy in Type 2 Diabetes; ARB and ACE-I in Diabetic Nephropathy; Low-Glycemic Index Diets and Diabetes
-
Vardenafil has been approved for the treatment of erectile dysfunction in men. The drug is the second oral type 5 phosphodiestase (PDE5) inhibitor approved for this indication along with sildenafil (Viagra).
-
There are arguments about the optimal treatment for ulcers with nonbleeding visible vessels and adherent clots. This study showed that the combination of endoscopic hemostasis with IV proton pump inhibitor therapy is superior to PPI alone in management of such patients.
-
Stroke with no determined cause, or cryptogenic stroke (CS), accounts for nearly 40% of all ischemic strokes. Traditionally, it has been held that CS carries a more benign prognosis than other stroke subtypes. However, until this recent study, the long-term risk of recurrent stroke in this large segment of the stroke population had never been prospectively studied.